Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
出版年份 2022 全文链接
标题
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
作者
关键词
-
出版物
World Allergy Organization Journal
Volume 15, Issue 12, Pages 100719
出版商
Elsevier BV
发表日期
2022-11-15
DOI
10.1016/j.waojou.2022.100719
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
- (2022) Weiru Yuan et al. Dermatologic Therapy
- Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
- (2021) Yudi Chen et al. World Allergy Organization Journal
- Predictors of treatment response in chronic spontaneous urticaria
- (2021) Jie Shen Fok et al. ALLERGY
- EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
- (2021) Ioana Agache et al. ALLERGY
- The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- (2021) T. Zuberbier et al. ALLERGY
- The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
- (2021) Mario Sánchez-Borges et al. World Allergy Organization Journal
- Urticaria and Angioedema Across the Ages
- (2020) Sarbjit Saini et al. Journal of Allergy and Clinical Immunology-In Practice
- Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series
- (2020) Anne Ari et al. PEDIATRIC DERMATOLOGY
- Omalizumab in children and adolescents with chronic urticaria: A 16‐week real‐world study
- (2020) Xiao‐ting Song et al. ALLERGY
- Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study
- (2019) Andac Salman et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta‐analysis
- (2019) Julia Fricke et al. ALLERGY
- Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study
- (2018) M.N. Ghazanfar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients
- (2018) Maria-Magdalena Balp et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
- (2018) Murat Türk et al. ALLERGOLOGY INTERNATIONAL
- Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients
- (2018) A.V. Marzano et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know
- (2017) Pavel Kolkhir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study
- (2017) Bo Ri Kim et al. JOURNAL OF DERMATOLOGY
- Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients
- (2016) M.N. Ghazanfar et al. BRITISH JOURNAL OF DERMATOLOGY
- Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis
- (2016) S. Guillén-Aguinaga et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
- (2013) Moises Labrador-Horrillo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More